About: Craig M. Crews

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Craig M. Crews Goto Sponge NotDistinct Permalink

An Entity of Type : wikidata:Q901, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/c/2xMFb3ZeQi

Craig M. Crews (born June 1, 1964) is an American scientist at Yale University. He is the John C. Malone Professor of Molecular, Cellular, and Developmental Biology, and also holds joint appointments in the departments of Chemistry and Pharmacology. Crews is the Executive Director of the Yale Center for Molecular Discovery and a former Editor of the journal Cell Chemical Biology. His research interests focus on chemical biology, particularly on controlled proteostasis. Crews is a pioneer in the field of targeted protein degradation and his lab's research led to the development of the anti-cancer drug carfilzomib (Kyprolis). He is the founder of Arvinas, the first biotechnology company to bring PROTAC drugs into clinical trials. In 2019, he was named an American Cancer Society Research Prof

Attributes	Values
rdf:type	Thing foaf:Person person dul:NaturalPerson Eukaryote Person Human Animal animal eukaryote scientist species schema:Person Scientist
rdfs:label	Craig M. Crews (en)
rdfs:comment	Craig M. Crews (born June 1, 1964) is an American scientist at Yale University. He is the John C. Malone Professor of Molecular, Cellular, and Developmental Biology, and also holds joint appointments in the departments of Chemistry and Pharmacology. Crews is the Executive Director of the Yale Center for Molecular Discovery and a former Editor of the journal Cell Chemical Biology. His research interests focus on chemical biology, particularly on controlled proteostasis. Crews is a pioneer in the field of targeted protein degradation and his lab's research led to the development of the anti-cancer drug carfilzomib (Kyprolis). He is the founder of Arvinas, the first biotechnology company to bring PROTAC drugs into clinical trials. In 2019, he was named an American Cancer Society Research Prof (en)
foaf:name	Craig M. Crews (en)
name	Craig M. Crews (en)
birth date	1964-06-01 (xsd:date)
dct:subject	Living people 1964 births American biochemists Harvard University alumni University of Virginia alumni Yale University faculty
Wikipage page ID	50342947 (xsd:integer)
Wikipage revision ID	1105633581 (xsd:integer)
Link from a Wikipage to another Wikipage	Cancer Research Institute Carfilzomib Proteasome inhibitor Proteolix Royal Society of Chemistry Pharmacology Ubiquitin ligase University of Tübingen University of Virginia Proteolysis targeting chimera Living people Chemical biology Onyx Pharmaceuticals Proteolysis Epoxomicin German Academic Exchange Service Multiple myeloma Proteolysis Targeting Chimera Stuart Schreiber 1964 births American biochemists Harvard University alumni University of Virginia alumni Yale University faculty Heinrich Wieland Prize Raymond L. Erikson American Association for Cancer Research Cell Chemical Biology Harvard University Chemistry National Cancer Institute New Haven, Connecticut Yale University Medicinal chemistry Mitogen-activated protein kinase kinase Chemical Biology Scheele Award Molecular biology Proteostasis Technische Universität Dortmund Honorary doctoral degree
Link from a Wikipage to an external page	http://www.efmc.info/content.php%3Flangue=english&cle_menus=1176114008 https://www.rict2018.org/speakers http://www.aacr.org/Research/Awards/Pages/aacr-award-for-outstanding-achievement-in-chemistry-in-cancer-research___8470D6.aspx%23.WLx5tfnyvD4 http://crewslab.yale.edu http://www.arvinas.com http://ycmd.yale.edu http://www.cancer.gov/research/nci-role/spotlight/oia http://www.rsc.org/ScienceAndTechnology/Awards/KhoranaPrize/2018-Winner.asp
sameAs	Craig M. Crews Craig M. Crews Craig M. Crews Craig M. Crews Craig M. Crews
work institution	Yale University
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Cite_journal dbt:Refbegin dbt:Refend dbt:Reflist dbt:Short_description dbt:B-da dbt:Infobox_scientist
alma mater	University of Virginia Harvard University
birth date	1964-06-01 (xsd:date)
field	Chemical Biology
known for	Carfilzomib Proteolysis Targeting Chimera Controlled Proteostasis (en)
has abstract	Craig M. Crews (born June 1, 1964) is an American scientist at Yale University. He is the John C. Malone Professor of Molecular, Cellular, and Developmental Biology, and also holds joint appointments in the departments of Chemistry and Pharmacology. Crews is the Executive Director of the Yale Center for Molecular Discovery and a former Editor of the journal Cell Chemical Biology. His research interests focus on chemical biology, particularly on controlled proteostasis. Crews is a pioneer in the field of targeted protein degradation and his lab's research led to the development of the anti-cancer drug carfilzomib (Kyprolis). He is the founder of Arvinas, the first biotechnology company to bring PROTAC drugs into clinical trials. In 2019, he was named an American Cancer Society Research Professor at the Yale University. (en)
doctoral advisors	Stuart Schreiber Raymond L. Erikson

Faceted Search & Find service v1.17_git147 as of Sep 06 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3331 as of Sep 2 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 59 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software